Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Strattera QTc Concerns Addressed During Review; Lilly Avoids Warning

Executive Summary

Lilly's Strattera review provides one example of a successful effort by a sponsor to address potential safety issues for a pending application without agreeing to a risk management program

You may also be interested in...



FDA Pharmacogenomics Advisory Committee Will Oversee Data Submissions

FDA is forming a pharmacogenomics advisory committee to handle voluntary genomic data submissions, Office of Clinical Pharmacology & Biopharmaceutics Director Lawrence Lesko, PhD, said

FDA Pharmacogenomics Advisory Committee Will Oversee Data Submissions

FDA is forming a pharmacogenomics advisory committee to handle voluntary genomic data submissions, Office of Clinical Pharmacology & Biopharmaceutics Director Lawrence Lesko, PhD, said

Pharmacogenetic Data With Clinical Outcomes Should Be Described In Label

Pharmacogenetic variations with demonstrated clinical outcomes should be discussed in drug labeling, members of FDA's Clinical Pharmacology Subcommittee of the Advisory Committee for Pharmaceutical Science said at its April 23 meeting

UsernamePublicRestriction

Register

LL016481

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel